Review of miglustat for clinical management in Gaucher disease type 1.

Therapeutics and Clinical Risk Management
Can Ficicioglu

Abstract

Gaucher disease is a progressive lysosomal storage disorder caused by the deficiency of glucocerebrosidase, and characterized by intralysosomal storage of glucosylceramide that leads to dysfunction in multiple organ systems. Intravenous enzyme replacement with imiglucerase is the accepted standard for treatment of symptomatic patients and has been effective in reducing many of the signs and symptoms of type I Gaucher disease in the majority of patients without serious adverse effects. An alternative therapeutic approach is substrate reduction therapy with N-butyldeoxynojirimycin (NB-DNJ) (miglustat; Zavesca((R))), an imino sugar that reversibly inhibits glucosylceremide synthase and reduces intracellular storage of glucosylceramide. Miglustat was recently approved in Europe and the United States for symptomatic patients with mild to moderate clinical manifestations for whom enzyme replacement therapy is not an option. This review article discusses the results of clinical studies and use of miglustat as a therapeutic agent in patients with type I Gaucher disease.

Citations

Oct 3, 2014·World Journal of Radiology·William L SimpsonManisha Balwani
Feb 22, 2017·Orphanet Journal of Rare Diseases·Michael L GanzNeal Weinreb
Sep 25, 2018·Journal of Managed Care & Specialty Pharmacy·Luba NalysnykAlexandra Ward
Oct 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Izumi NakagomeShuichi Hirono
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hyun-Jun JangJang Hyun Choi
Sep 8, 2010·The New England Journal of Medicine·Harry C Dietz
Jun 17, 2018·The Biochemical Journal·Jeffrey M Arciola, Nicole A Horenstein
Dec 17, 2009·IUBMB Life·Michael Beck
Sep 4, 2009·Pediatric Annals·Elizabeth R Lim-Melia, David F Kronn
Aug 24, 2010·Neuromolecular Medicine·Matthias Eckhardt
Jul 27, 2010·Skeletal Radiology·Robert KatzBrian Holloway
Mar 16, 2021·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Immo SerbianRené Csuk
Jun 25, 2021·American Journal of Medical Genetics. Part a·Hilary J Vernon, Irini Manoli
Nov 16, 2016·Blood Cells, Molecules & Diseases·Tomer AdarAri Zimran

❮ Previous
Next ❯

Methods Mentioned

BETA
protein folding
glycosylation
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.